Home › Muscular Dystrophy › District of Columbia
Muscular Dystrophy clinical trials in District of Columbia
4 studies for Muscular Dystrophy are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
- Children's National Health System, Washington D.C.
RecruitingObservational study
Ages 2 and older · Men · Updated Sep 24, 2026 · NCT06564974A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
- Children's National Hospital, Washington D.C.
RecruitingObservational study
Ages 6 and older · All sexes · Updated Jul 2, 2026 · NCT07127978Duchenne Electronic Health Record Study
- Children's National Medical Center, Washington D.C.
RecruitingObservational study
All ages · All sexes · Updated May 27, 2026 · NCT07609394The Duchenne Registry
- The Duchenne Registry / PPMD, Washington D.C.
RecruitingObservational study
All ages · All sexes · Updated May 8, 2026 · NCT02069756From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.